Sterneck Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-14,235
Closed -$911K 144
2013
Q3
$911K Sell
14,235
-5,850
-29% -$374K 0.58% 55
2013
Q2
$623K Buy
+20,085
New +$623K 0.39% 75